Last reviewed · How we verify
Mirabegron 50 MG
Mirabegron 50 MG is a Small molecule drug developed by Hasanuddin University. It is currently FDA-approved. Also known as: Tamsulosin 0.4 mg, Placebo, Myrbertiq, Hibero.
At a glance
| Generic name | Mirabegron 50 MG |
|---|---|
| Also known as | Tamsulosin 0.4 mg, Placebo, Myrbertiq, Hibero, Myrbetriq |
| Sponsor | Hasanuddin University |
| Modality | Small molecule |
| Phase | FDA-approved |
Approved indications
Common side effects
Key clinical trials
- The Physiological Responses and Adaptation of Brown Adipose Tissue to Chronic Treatment With Beta3-Adrenergic Receptor Agonists (PHASE1)
- Mirabegron in Patients With Age-Related Macular Degeneration
- The Effects of Mirabegron and Tadalafil on Glucose Tolerance in Prediabetics (PHASE4)
- Mechanisms for Activation of Beige Adipose Tissue in Humans (PHASE2)
- Behavioral Interventions Versus Pelvic Floor Muscle Therapy as Adjuncts to Anticholinergic Pharmacotherapy for Urgency Urinary Incontinence: A Non-Inferiority Trial (NA)
- Comparison of Mirabegron and Tamsulosin for Ureteral Stone Expulsion (PHASE4)
- Comparative Effectiveness of Initial OAB Treatment Options Among Older Women at High Risk of Falls (EARLY_PHASE1)
- Beta-Agonist Versus OnabotulinumtoxinA Trial for Urgency Urinary Incontinence (PHASE4)
Primary sources
Every claim on this page is sourced from regulatory or scientific primary sources. See our editorial policy for full methodology.
| Source | Used for |
|---|---|
| ClinicalTrials.gov | Trial enrolment, design, endpoints, results |
Competitive intelligence
For the full competitive landscape — auto-detected comparators, recent regulatory actions across the set, upcoming PDUFA, patent timeline, sponsor landscape:
- Mirabegron 50 MG CI brief — competitive landscape report
- Mirabegron 50 MG updates RSS · CI watch RSS
- Hasanuddin University portfolio CI
Frequently asked questions about Mirabegron 50 MG
What is Mirabegron 50 MG?
Mirabegron 50 MG is a Small molecule drug developed by Hasanuddin University.
Who makes Mirabegron 50 MG?
Mirabegron 50 MG is developed and marketed by Hasanuddin University (see full Hasanuddin University pipeline at /company/hasanuddin-university).
Is Mirabegron 50 MG also known as anything else?
Mirabegron 50 MG is also known as Tamsulosin 0.4 mg, Placebo, Myrbertiq, Hibero, Myrbetriq.
What development phase is Mirabegron 50 MG in?
Mirabegron 50 MG is FDA-approved (marketed).
Related
- Manufacturer: Hasanuddin University — full pipeline
- Also known as: Tamsulosin 0.4 mg, Placebo, Myrbertiq, Hibero, Myrbetriq
Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing